Knight Therapeutics, Inc. (GUD.TO)
9.75
+0.09
(+0.93%)
CAD |
TSX |
Aug 25, 16:00
Knight Therapeutics Shareholders Equity (Quarterly) : 798.59M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 798.59M |
| March 31, 2026 | 787.27M |
| December 31, 2025 | 767.27M |
| September 30, 2025 | 766.79M |
| June 30, 2025 | 763.06M |
| March 31, 2025 | 795.44M |
| December 31, 2024 | 795.10M |
| September 30, 2024 | 773.91M |
| June 30, 2024 | 762.80M |
| March 31, 2024 | 761.89M |
| December 31, 2023 | 746.87M |
| September 30, 2023 | 814.66M |
| June 30, 2023 | 807.20M |
| March 31, 2023 | 818.87M |
| December 31, 2022 | 825.86M |
| September 30, 2022 | 854.52M |
| June 30, 2022 | 829.69M |
| March 31, 2022 | 829.58M |
| December 31, 2021 | 842.02M |
| September 30, 2021 | 872.60M |
| June 30, 2021 | 889.44M |
| March 31, 2021 | 829.48M |
| December 31, 2020 | 886.24M |
| September 30, 2020 | 882.22M |
| June 30, 2020 | 791.87M |
| Date | Value |
|---|---|
| March 31, 2020 | 783.56M |
| December 31, 2019 | 810.73M |
| September 30, 2019 | 958.18M |
| June 30, 2019 | 1.048B |
| March 31, 2019 | 1.033B |
| December 31, 2018 | 1.030B |
| September 30, 2018 | 1.020B |
| June 30, 2018 | 1.013B |
| March 31, 2018 | 1.001B |
| December 31, 2017 | 991.21M |
| September 30, 2017 | 980.45M |
| June 30, 2017 | 980.18M |
| March 31, 2017 | 983.30M |
| December 31, 2016 | 979.72M |
| September 30, 2016 | 869.60M |
| June 30, 2016 | 861.96M |
| March 31, 2016 | 632.67M |
| December 31, 2015 | 642.06M |
| September 30, 2015 | 625.45M |
| June 30, 2015 | 526.34M |
| March 31, 2015 | 519.45M |
| December 31, 2014 | 478.99M |
| September 30, 2014 | 260.58M |
| June 30, 2014 | 258.56M |
| March 31, 2014 | 83.49M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 78.37M |
| Bausch Health Cos., Inc. | -2.513B |
| Cipher Pharmaceuticals, Inc. | 194.73M |
| BioSyent, Inc. | 45.84M |
| Revive Therapeutics Ltd. | -4.025M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.045B |
| Total Liabilities (Quarterly) | 246.25M |
| Debt to Equity Ratio | 0.0429 |
| Current Ratio | 2.280 |
| Net Debt Paydown Yield | 0.41% |